Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients

被引：11

作者：

Uwagawa, Tadashi ^{[1
]}

Misawa, Takeyuki ^{[1
]}

Iida, Tomonori ^{[1
]}

Sakamoto, Taro ^{[1
]}

Gocho, Takeshi ^{[1
]}

Wakiyama, Shigeki ^{[1
]}

Hirohara, Shoichi ^{[1
]}

Yanaga, Katsuhiko ^{[1
]}

机构：

[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan

来源：

JOURNAL OF PALLIATIVE MEDICINE | 2010年 / 13卷 / 07期

关键词：

RECOMMENDATIONS; GUIDELINES; THERAPY;

D O I：

10.1089/jpm.2009.0404

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.

引用

页码：815 / 818

页数：4

共 50 条

[21] Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors
Valentin Becker
Stefan Grotz
Christoph Schlag
Simon Nennstiel
Analena Beitz
Bernhard Haller
Roland M Schmid
Alexander Meining
Monther Bajbouj
World Journal of Gastroenterology, 2014, (14) : 4017 - 4024
[22] The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease
Pace, Fabio
Pace, Marina
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 423 - 427
[23] Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited
Lada, Michal J.
Nieman, Dylan R.
Han, Michelle
Timratana, Poochong
Alsalahi, Omran
Peyre, Christian G.
Jones, Carolyn E.
Watson, Thomas J.
Peters, Jeffrey H.
SURGERY, 2013, 154 (04) : 856 - 864
[24] Proton Pump Inhibitor Therapy in Chemotherapy-induced Pancreatitis
Fettah, Ali
Yarali, Nese
Bayram, Cengiz
Kirsaclioglu, Ceyda T.
Tunc, Bahattin
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (08) : 660 - 661
[25] Long-term Efficacy of Proton-Pump Inhibitors in Japanese Elderly Patients with Gastroesophageal Reflux Disease
Arakawa, Tetsuo
Fujiwara, Yasuhiro
Tominaga, Kazunari
Watanabe, Toshio
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S6 - S6
[26] Work productivity and response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease
Wahlqvist, Peter
Ducrotte, Philippe
Jones, Roger
Liker, Harley
GASTROENTEROLOGY, 2007, 132 (04) : A350 - A350
[27] Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
Shi, Yichao
Li, Jianfeng
Cai, Shuntian
Zhao, Hong
Zhao, Huijun
Sun, Gang
Yang, Yunsheng
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
[28] The putative mechanisms for proton pump inhibitor's failure in patients with gastroesophageal reflux disease
Fass, Ronnie
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 42 - 42
[29] Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review
Miyazaki, Hirota
Igarashi, Ataru
Takeuchi, Toshihisa
Teng, Lida
Uda, Akihito
Deguchi, Hisato
Higuchi, Kazuhide
Tango, Toshiro
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (08) : 1316 - 1328
[30] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
Kunsch, S.
Neesse, A.
Linhart, T.
Nell, C.
Gress, T. M.
Ellenrieder, V.
DIGESTION, 2012, 86 (04) : 315 - 322

← 1 2 3 4 5 →